For example, it is plausible that Msh2−/− deficiency in the K-rasLA1/+ mice accelerated the acquisition of mutations within the p53 gene, or other genes such as the TGF-β receptor 6, that could potentially play a role in promoting adenocarcinoma development. This evidence concerns the gene MSH2 and adenocarcinoma.